Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks' Gestation.

Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome.

Recurrent HELLP Syndrome at 22 Weeks of Gestation.

Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes.

Uterine artery pulsatility index at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.

Antenatal corticosteroids and perinatal outcomes in infants born at 23-25 weeks of gestation.

Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.

Elective caesarean section at 38 versus 39 weeks of gestation: neonatal and maternal outcomes in a randomised controlled trial.

Perinatal Outcomes of Monochorionic-Diamniotic Twin Pregnancies Uncomplicated at 28 Weeks of Gestation.

Severe preeclampsia in preterm pregnancy between 26 and 32 weeks' gestation.

Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome.

Association of isolated polyhydramnios at or beyond 34 weeks of gestation and pregnancy outcome.

The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation.

Association between shortened cervical length at 34-36 weeks' gestation and term labour in Asian women.

Influence of perinatal factors in short- and long-term outcomes of infants born at 23 weeks of gestation.

P46. TOTEM study (temporise or terminate pregnancy in women with severe preeclampsia at 28-34 weeks): A study protocol.

Posterior reversible encephalopathy syndrome in patient of severe preeclampsia with Hellp syndrome immediate postpartum.

Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation.

Bilateral Vision Loss after Delivery in Two Cases: Severe Preeclampsia and HELLP Syndrome.

Risk factors and perinatal outcomes associated with latency in preterm premature rupture of membranes between 24 and 34 weeks of gestation.

Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis.

Prenatal diagnosis of Fraser syndrome at 18.5 weeks gestation, with autopsy findings at 19 weeks.

Genetic aspects of preeclampsia and the HELLP syndrome.

Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe.

Maternal arrhythmia and perinatal outcomes.

Suggest Documents

Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome.

Recurrent HELLP Syndrome at 22 Weeks of Gestation.

Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes.

Uterine artery pulsatility index at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.

Antenatal corticosteroids and perinatal outcomes in infants born at 23-25 weeks of gestation.

Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.

Elective caesarean section at 38 versus 39 weeks of gestation: neonatal and maternal outcomes in a randomised controlled trial.

Perinatal Outcomes of Monochorionic-Diamniotic Twin Pregnancies Uncomplicated at 28 Weeks of Gestation.

Severe preeclampsia in preterm pregnancy between 26 and 32 weeks' gestation.

Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome.

Association of isolated polyhydramnios at or beyond 34 weeks of gestation and pregnancy outcome.

The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation.

Association between shortened cervical length at 34-36 weeks' gestation and term labour in Asian women.

Influence of perinatal factors in short- and long-term outcomes of infants born at 23 weeks of gestation.

P46. TOTEM study (temporise or terminate pregnancy in women with severe preeclampsia at 28-34 weeks): A study protocol.

Posterior reversible encephalopathy syndrome in patient of severe preeclampsia with Hellp syndrome immediate postpartum.

Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation.

Bilateral Vision Loss after Delivery in Two Cases: Severe Preeclampsia and HELLP Syndrome.

Risk factors and perinatal outcomes associated with latency in preterm premature rupture of membranes between 24 and 34 weeks of gestation.

Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis.

Prenatal diagnosis of Fraser syndrome at 18.5 weeks gestation, with autopsy findings at 19 weeks.

Genetic aspects of preeclampsia and the HELLP syndrome.

Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe.

Maternal arrhythmia and perinatal outcomes.

Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks' Gestation.

Recommend Documents

Follow Us